HTFL vs LENZ: fair value comparison
Heartflow, Inc. and LENZ Therapeutics, Inc. · Updated 2026-10-19
HTFL has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. LENZ has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, HTFL currently ranks higher by quality score.
| HTFL | LENZ | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $48.29 | $3.27 |
| 12-month range | $20.49–$52.21 | $3.27–$31.97 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #188 of 301 Healthcare | #190 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Low | Low |
| Margin trend | Expanding | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | Downtrend |
| 52-week position | The top quarter | The bottom quarter |
Full single-stock breakdowns: HTFL fair value analysis · LENZ fair value analysis